196 related articles for article (PubMed ID: 28637808)
1. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
5. Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway.
Yang SQ; Chen YD; Li H; Hui X; Gao WY
Arch Med Res; 2018 Jul; 49(5):314-322. PubMed ID: 30409503
[TBL] [Abstract][Full Text] [Related]
6. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
7. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
9. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
[TBL] [Abstract][Full Text] [Related]
10. On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.
Gao ZG; Jacobson KA
Biochem Pharmacol; 2016 May; 107():59-66. PubMed ID: 26954502
[TBL] [Abstract][Full Text] [Related]
11. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
Zhou TT; Zhao T; Ma F; Zhang YN; Jiang J; Ruan Y; Yan QY; Wang GH; Ren J; Guan XW; Guo J; Zhao YH; Ye JM; Hu LH; Chen J; Shen X
Acta Pharmacol Sin; 2019 Sep; 40(9):1193-1204. PubMed ID: 30833709
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin.
Liu HY; Collins QF; Moukdar F; Zhuo D; Han J; Hong T; Collins S; Cao W
J Biol Chem; 2008 May; 283(18):12056-63. PubMed ID: 18347011
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
14. Hepatic overexpression of ATP synthase β subunit activates PI3K/Akt pathway to ameliorate hyperglycemia of diabetic mice.
Wang C; Chen Z; Li S; Zhang Y; Jia S; Li J; Chi Y; Miao Y; Guan Y; Yang J
Diabetes; 2014 Mar; 63(3):947-59. PubMed ID: 24296716
[TBL] [Abstract][Full Text] [Related]
15. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.
Ozcan L; Wong CC; Li G; Xu T; Pajvani U; Park SK; Wronska A; Chen BX; Marks AR; Fukamizu A; Backs J; Singer HA; Yates JR; Accili D; Tabas I
Cell Metab; 2012 May; 15(5):739-51. PubMed ID: 22503562
[TBL] [Abstract][Full Text] [Related]
16. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.
Bähr I; Mühlbauer E; Albrecht E; Peschke E
J Pineal Res; 2012 Nov; 53(4):390-8. PubMed ID: 22672634
[TBL] [Abstract][Full Text] [Related]
17. 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway.
Shi Y; Qiao J; Mu B; Zuo B; Yuan J
Biochem Biophys Res Commun; 2017 Nov; 493(1):286-290. PubMed ID: 28911865
[TBL] [Abstract][Full Text] [Related]
18. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]